[HTML][HTML] Nicotinic acetylcholine receptors and epilepsy

A Becchetti, LC Grandi, M Cerina, A Amadeo - Pharmacological Research, 2023 - Elsevier
Despite recent advances in understanding the causes of epilepsy, especially the genetic,
comprehending the biological mechanisms that lead to the epileptic phenotype remains …

Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models

H Javed, MF Nagoor Meeran, S Azimullah… - Frontiers in …, 2019 - frontiersin.org
α-Synuclein (α-syn) is a presynaptic protein that regulates the release of neurotransmitters
from synaptic vesicles in the brain. α-Syn aggregates, including Lewy bodies, are features of …

Nicotinic acetylcholine receptor redux: Discovery of accessories opens therapeutic vistas

JA Matta, S Gu, WB Davini, DS Bredt - Science, 2021 - science.org
BACKGROUND One hundred years ago, experiments on beating frog hearts identified
acetylcholine (ACh) as the seminal neurotransmitter. Sixty years later, fractionation of the eel …

Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases

AS Vallés, FJ Barrantes - Cells, 2023 - mdpi.com
The cholinergic system plays an essential role in brain development, physiology, and
pathophysiology. Herein, we review how specific alterations in this system, through genetic …

Inside-out neuropharmacology of nicotinic drugs

BJ Henderson, HA Lester - Neuropharmacology, 2015 - Elsevier
Upregulation of neuronal nicotinic acetylcholine receptors (AChRs) is a venerable result of
chronic exposure to nicotine; but it is one of several consequences of pharmacological …

[HTML][HTML] Chronic exposure to neonicotinoids increases neuronal vulnerability to mitochondrial dysfunction in the bumblebee (Bombus terrestris)

C Moffat, JG Pacheco, S Sharp, AJ Samson… - The FASEB …, 2015 - ncbi.nlm.nih.gov
The global decline in the abundance and diversity of insect pollinators could result from
habitat loss, disease, and pesticide exposure. The contribution of the neonicotinoid …

Succinic semialdehyde dehydrogenase deficiency: an update

M Didiasova, A Banning, H Brennenstuhl… - Cells, 2020 - mdpi.com
Succinic semialdehyde dehydrogenase deficiency (SSADH-D) is a genetic disorder that
results from the aberrant metabolism of the neurotransmitter γ-amino butyric acid (GABA) …

Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors

J Wang, J Lindstrom - British journal of pharmacology, 2018 - Wiley Online Library
Heteromeric nicotinic ACh receptors (nAChRs) were thought to have two orthodox agonist‐
binding sites at two α/β subunit interfaces. Highly selective ligands are hard to develop by …

Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors

AV Shivange, PM Borden, AK Muthusamy… - Journal of General …, 2019 - rupress.org
Nicotine dependence is thought to arise in part because nicotine permeates into the
endoplasmic reticulum (ER), where it binds to nicotinic receptors (nAChRs) and begins an …

Getting a handle on neuropharmacology by targeting receptor-associated proteins

MP Maher, JA Matta, S Gu, M Seierstad, DS Bredt - Neuron, 2017 - cell.com
Targeted therapy for neuropsychiatric disorders requires selective modulation of
dysfunctional neuronal pathways. Receptors relevant to CNS disorders typically have …